ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633713 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633713; 2) Community: the network communities that were significantly associated with the response to NSC 633713; 3) Molecule: the relationships between components within communities and NSC 633713; 4) MDR: the compounds that were significantly associated with the NSC 633713.

NSC Compound Enrichment Correlation
NSC 176323 Camptothecin Derivative 0.0208632511155816 0.44023598
NSC 176328 Ellipticine, 6-(3-aminopropyl)-, dihydrochloride 0.0208632511155816 0.45455616
NSC 359415 Null 0.0208632511155816 0.47102441
NSC 382032 Null 0.0208632511155816 0.52850842
NSC 58573 Pyrimidine, 2,4,5-trichloro-6-ethyl- 0.0208632511155816 0.22412896
NSC 616960 2[5H]-Furanone, 5-[(.beta.-D-glucopyranosyloxy)methyl]-,(S)- (9CI) 0.0208632511155816 0.33118085
NSC 624191 Null 0.0208632511155816 0.24359339
NSC 636984 Null 0.0208632511155817 0.50225537
NSC 638645 Null 0.0208632511155817 0.46391712
NSC 642009 Butanedioic acid, 2-[[2-[(3-chloro-1,4-dihydro-1,4-dioxo- 2-naphthalenyl)amino]1,2-dioxo]ethyl]-3-oxo-, dimethyl ester 0.0208632511155817 0.2920997
Total:130  Current:63    [First] [Prev] [Next] [Last]